Due to these results, the authors conclude that targeting the NEDD4L/RASGRP2 axis or inducing RASGRP2-modified ADMSCs exosomes could be a strategy for alleviating diabetes-related atherosclerosis. The gene discussed is NEDD4L; the disease is atherosclerosis.